 - Patients must have evidence of disease progression while receiving androgen suppression therapy by orchiectomy or other primary hormonal therapy including, but not limited to LHRH agonist therapy e.g., leuprolide or goserelin or LHRH antagonist e.g. aberelix. Note: patients who have not undergone bilateral orchiectomy must continue LHRH therapy while on protocol 